These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients. Alemayehu A; Sebova K; Fridrichova I Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713 [TBL] [Abstract][Full Text] [Related]
26. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827 [TBL] [Abstract][Full Text] [Related]
27. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. Kastrinos F; Ojha RP; Leenen C; Alvero C; Mercado RC; Balmaña J; Valenzuela I; Balaguer F; Green R; Lindor NM; Thibodeau SN; Newcomb P; Win AK; Jenkins M; Buchanan DD; Bertario L; Sala P; Hampel H; Syngal S; Steyerberg EW; J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26582061 [TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Poynter JN; Siegmund KD; Weisenberger DJ; Long TI; Thibodeau SN; Lindor N; Young J; Jenkins MA; Hopper JL; Baron JA; Buchanan D; Casey G; Levine AJ; Le Marchand L; Gallinger S; Bapat B; Potter JD; Newcomb PA; Haile RW; Laird PW; Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3208-15. PubMed ID: 18990764 [TBL] [Abstract][Full Text] [Related]
29. Risk of cancer in cases of suspected lynch syndrome without germline mutation. Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017 [TBL] [Abstract][Full Text] [Related]
30. Population-based screening for Lynch syndrome in Western Australia. Schofield L; Grieu F; Amanuel B; Carrello A; Spagnolo D; Kiraly C; Pachter N; Goldblatt J; Platell C; Levitt M; Stewart C; Salama P; Ee H; Raftopoulous S; Katris P; Threlfall T; Edkins E; Wallace M; Iacopetta B Int J Cancer; 2014 Sep; 135(5):1085-91. PubMed ID: 24474394 [TBL] [Abstract][Full Text] [Related]
31. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer. Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC; JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542 [TBL] [Abstract][Full Text] [Related]
32. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time? Søreide K Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726 [TBL] [Abstract][Full Text] [Related]
33. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. Balmaña J; Balaguer F; Castellví-Bel S; Steyerberg EW; Andreu M; Llor X; Jover R; Castells A; Syngal S; J Med Genet; 2008 Sep; 45(9):557-63. PubMed ID: 18603628 [TBL] [Abstract][Full Text] [Related]
34. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome. Mas-Moya J; Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK Hum Pathol; 2015 Nov; 46(11):1616-25. PubMed ID: 26319271 [TBL] [Abstract][Full Text] [Related]
36. Multivariate analysis as a method for evaluating the pathogenicity of novel genetic MLH1 variants in patients with colorectal cancer and microsatellite instability. Duraturo F; Liccardo R; Cavallo A; De Rosa M; Rossi GB; Izzo P Int J Mol Med; 2015 Aug; 36(2):511-7. PubMed ID: 26096739 [TBL] [Abstract][Full Text] [Related]
37. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. Bouzourene H; Hutter P; Losi L; Martin P; Benhattar J Fam Cancer; 2010 Jun; 9(2):167-72. PubMed ID: 19949877 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas. Boissière-Michot F; Frugier H; Ho-Pun-Cheung A; Lopez-Crapez E; Duffour J; Bibeau F Virchows Arch; 2016 Aug; 469(2):135-44. PubMed ID: 27220764 [TBL] [Abstract][Full Text] [Related]
39. Early-onset colorectal cancer is an easy and effective tool to identify retrospectively Lynch syndrome. Perea J; Rodríguez Y; Rueda D; Marín JC; Díaz-Tasende J; Álvaro E; Alegre C; Osorio I; Colina F; Lomas M; Hidalgo M; Benítez J; Urioste M Ann Surg Oncol; 2011 Nov; 18(12):3285-91. PubMed ID: 21590452 [TBL] [Abstract][Full Text] [Related]
40. Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome. Manders P; Spruijt L; Kets CM; Willems HW; Bodmer D; Hebeda KM; Nagtegaal ID; van Krieken JH; Ligtenberg MJ; Hoogerbrugge N Eur J Cancer; 2011 Jun; 47(9):1407-13. PubMed ID: 21273057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]